{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:53:44Z","timestamp":1791831224385,"version":"4.3.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1681\/asn.2010111196","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T22:06:15Z","timestamp":1314309975000},"page":"1863-1875","source":"Crossref","is-referenced-by-count":118,"title":["Valproic Acid Attenuates Proteinuria and Kidney Injury"],"prefix":"10.1681","volume":"22","author":[{"given":"Katrien","family":"Van Beneden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Geers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Mannaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierik","family":"Verbeelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.","family":"van Grunsven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Van den Branden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20230423","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1523-1755.1998.00044.x","article-title":"Progression of glomerular diseases: Is the podocyte the culprit?","volume":"54","author":"Kriz","year":"1998","journal-title":"Kidney Int"},{"key":"R2-14-20230423","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000044974","article-title":"Experimental focal segmental glomerulosclerosis in mice","volume":"78","author":"Chen","year":"1998","journal-title":"Nephron"},{"key":"R3-14-20230423","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.1986.28","article-title":"Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease","volume":"29","author":"Okuda","year":"1986","journal-title":"Kidney Int"},{"key":"R4-14-20230423","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","article-title":"Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events","volume":"58","author":"Wang","year":"2000","journal-title":"Kidney Int"},{"key":"R5-14-20230423","doi-asserted-by":"crossref","first-page":"F213","DOI":"10.1152\/ajprenal.90421.2008","article-title":"Inducible rodent models of acquired podocyte diseases","volume":"296","author":"Pippin","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R6-14-20230423","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.23334","article-title":"Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo","volume":"51","author":"Mannaerts","year":"2010","journal-title":"Hepatology"},{"key":"R7-14-20230423","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.510290328","article-title":"A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture","volume":"29","author":"Niki","year":"1999","journal-title":"Hepatology"},{"key":"R8-14-20230423","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0168-8278(02)00275-1","article-title":"Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor","volume":"37","author":"Rombouts","year":"2002","journal-title":"J Hepatol"},{"key":"R9-14-20230423","first-page":"239","article-title":"Trichostatin A, lead compound for development of antifibrogenic drugs","volume":"64","author":"Rombouts","year":"2001","journal-title":"Acta Gastroenterol Belg"},{"key":"R10-14-20230423","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCRESAHA.109.209338","article-title":"Protein acetylation in the cardiorenal axis: The promise of histone deacetylase inhibitors","volume":"106","author":"Bush","year":"2010","journal-title":"Circ Res"},{"key":"R11-14-20230423","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.110.168385","article-title":"Histone deacetylase: A potential therapeutic target for fibrotic disorders","volume":"335","author":"Pang","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-14-20230423","doi-asserted-by":"crossref","first-page":"F133","DOI":"10.1152\/ajprenal.00400.2009","article-title":"Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury","volume":"298","author":"Marumo","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R13-14-20230423","doi-asserted-by":"crossref","first-page":"F996","DOI":"10.1152\/ajprenal.00282.2009","article-title":"Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy","volume":"297","author":"Pang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R14-14-20230423","doi-asserted-by":"crossref","first-page":"21819","DOI":"10.1073\/pnas.0911987106","article-title":"Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models","volume":"106","author":"Cao","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-14-20230423","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00086.2009","article-title":"Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury","volume":"297","author":"Noh","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R16-14-20230423","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/ndt\/gfp730","article-title":"Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10","volume":"25","author":"Sayyed","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R17-14-20230423","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J Clin Invest"},{"key":"R18-14-20230423","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1681\/ASN.2005111187","article-title":"Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells","volume":"18","author":"Yoshikawa","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R19-14-20230423","doi-asserted-by":"crossref","first-page":"F426","DOI":"10.1152\/ajprenal.00107.2009","article-title":"Effects of histone deacetylase inhibitors on rat mesangial cells","volume":"298","author":"Freidkin","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R20-14-20230423","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1681\/ASN.2009080851","article-title":"Inhibition of histone deacetylase expands the renal progenitor cell population","volume":"21","author":"de Groh","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R21-14-20230423","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1634\/stemcells.2007-0049","article-title":"Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury","volume":"25","author":"Imai","year":"2007","journal-title":"Stem Cells"},{"key":"R22-14-20230423","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/med.20027","article-title":"Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies","volume":"25","author":"Blaheta","year":"2005","journal-title":"Med Res Rev"},{"key":"R23-14-20230423","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J"},{"key":"R24-14-20230423","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem J"},{"key":"R25-14-20230423","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase inhibitors: novel drugs for the treatment of cancer","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"R26-14-20230423","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"R27-14-20230423","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.resuscitation.2010.09.469","article-title":"Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells","volume":"82","author":"Zacharias","year":"2011","journal-title":"Resuscitation"},{"key":"R28-14-20230423","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000045838","article-title":"Cytokine gene expression in Adriamycin nephropathy: Effects of antioxidant nuclear factor kappaB inhibitors in established disease","volume":"86","author":"Rangan","year":"2000","journal-title":"Nephron"},{"key":"R29-14-20230423","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1523-1755.2004.66038.x","article-title":"CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome","volume":"66","author":"Vielhauer","year":"2004","journal-title":"Kidney Int"},{"key":"R30-14-20230423","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1523-1755.2005.00323.x","article-title":"DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy","volume":"67","author":"Wu","year":"2005","journal-title":"Kidney Int"},{"key":"R31-14-20230423","doi-asserted-by":"crossref","first-page":"F1140","DOI":"10.1152\/ajprenal.00216.2009","article-title":"The CDK-inhibitor p21 is Pro-survival in adriamycin(R)-induced podocyte injury, in vitro and in vivo","volume":"298","author":"Marshall","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R32-14-20230423","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2007121328","article-title":"Urine podocyte mRNAs mark progression of renal disease","volume":"20","author":"Sato","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R33-14-20230423","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1093\/ndt\/gfn290","article-title":"CRBP-I in the renal tubulointerstitial compartment of healthy rats and rats with renal fibrosis","volume":"23","author":"Van Beneden","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R34-14-20230423","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1681\/ASN.2007111205","article-title":"Adriamycin alters glomerular endothelium to induce proteinuria","volume":"20","author":"Jeansson","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R35-14-20230423","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1073\/pnas.0409786102","article-title":"A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse","volume":"102","author":"Zheng","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-14-20230423","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ki.2009.424","article-title":"Proteinuria: An enzymatic disease of the podocyte?","volume":"77","author":"Mundel","year":"2010","journal-title":"Kidney Int"},{"key":"R37-14-20230423","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","article-title":"The podocyte's response to injury: Role in proteinuria and glomerulosclerosis","volume":"69","author":"Shankland","year":"2006","journal-title":"Kidney Int"},{"key":"R38-14-20230423","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000028027","article-title":"Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis","volume":"66","author":"Shiiki","year":"1998","journal-title":"Pathobiology"},{"key":"R39-14-20230423","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0002-9440(10)63378-0","article-title":"Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology","volume":"165","author":"Griffin","year":"2004","journal-title":"Am J Pathol"},{"key":"R40-14-20230423","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1681\/ASN.2008121226","article-title":"New insights into epithelial-mesenchymal transition in kidney fibrosis","volume":"21","author":"Liu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R41-14-20230423","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1681\/ASN.2008050513","article-title":"Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition","volume":"19","author":"Zeisberg","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R42-14-20230423","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.2010.137","article-title":"Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria","volume":"78","author":"Kang","year":"2010","journal-title":"Kidney Int"},{"key":"R43-14-20230423","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.ki.5002291","article-title":"Podocytes in culture: Past, present, and future","volume":"72","author":"Shankland","year":"2007","journal-title":"Kidney Int"},{"key":"R44-14-20230423","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1681\/ASN.2010060633","article-title":"Epigenetic histone methylation modulates fibrotic gene expression","volume":"21","author":"Sun","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R45-14-20230423","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: A commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem Int"},{"key":"R47-14-20230423","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"R48-14-20230423","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ndt\/16.1.147","article-title":"Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis","volume":"16","author":"Deman","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R49-14-20230423","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000057614","article-title":"Vitamin E protects renal antioxidant enzymes and attenuates glomerulosclerosis in adriamycin-treated rats","volume":"91","author":"Van den Branden","year":"2002","journal-title":"Nephron"},{"key":"R50-14-20230423","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","article-title":"Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo","volume":"66","author":"Xia","year":"2006","journal-title":"Cancer Res"},{"key":"R51-14-20230423","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ki.2009.9","article-title":"Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt","volume":"75","author":"Lea","year":"2009","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201110000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:34:05Z","timestamp":1786131245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201110000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2010111196","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}